| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
TransCode Therapeutics Inc. Common Stock (NASDAQ: RNAZ)
RNAZ Technical Analysis
3
| As on 15th Jan 2026 RNAZ STOCK Price closed @ 8.83 and we RECOMMEND Buy for LONG-TERM with Stoploss of 6.93 & Buy for SHORT-TERM with Stoploss of 6.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RNAZSTOCK Price
| Open | 8.88 | Change | Price | % |
| High | 9.16 | 1 Day | -0.19 | -2.11 |
| Low | 8.55 | 1 Week | 1.47 | 19.97 |
| Close | 8.83 | 1 Month | -0.12 | -1.34 |
| Volume | 11554 | 1 Year | 8.48 | 2422.86 |
| 52 Week High 15.23 | 52 Week Low 0.27 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| OCG | 0.01 | 0.00% |
| AUID | 1.71 | 72.73% |
| NVDA | 187.05 | 2.13% |
| INTC | 48.32 | -0.82% |
| LMDX | 0.02 | 0.00% |
| YGMZ | 0.02 | -66.67% |
| ONDS | 12.82 | -5.46% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RNAZ Daily Charts |
RNAZ Intraday Charts |
Whats New @ Bazaartrend |
RNAZ Free Analysis |
|
|
RNAZ Important Levels Intraday
| RESISTANCE | 10.01 |
| RESISTANCE | 9.63 |
| RESISTANCE | 9.40 |
| RESISTANCE | 9.16 |
| SUPPORT | 8.50 |
| SUPPORT | 8.26 |
| SUPPORT | 8.03 |
| SUPPORT | 7.65 |
RNAZ Forecast January 2026
| 4th UP Forecast | 35.94 |
| 3rd UP Forecast | 27.25 |
| 2nd UP Forecast | 21.87 |
| 1st UP Forecast | 16.5 |
| 1st DOWN Forecast | 1.16 |
| 2nd DOWN Forecast | -4.21 |
| 3rd DOWN Forecast | -9.59 |
| 4th DOWN Forecast | -18.28 |
RNAZ Weekly Forecast
| 4th UP Forecast | 12.84 |
| 3rd UP Forecast | 11.55 |
| 2nd UP Forecast | 10.76 |
| 1st UP Forecast | 9.96 |
| 1st DOWN Forecast | 7.70 |
| 2nd DOWN Forecast | 6.90 |
| 3rd DOWN Forecast | 6.11 |
| 4th DOWN Forecast | 4.82 |
RNAZ Forecast2026
| 4th UP Forecast | 48.85 |
| 3rd UP Forecast | 36.02 |
| 2nd UP Forecast | 28.08 |
| 1st UP Forecast | 20.15 |
| 1st DOWN Forecast | -2.49 |
| 2nd DOWN Forecast | -10.42 |
| 3rd DOWN Forecast | -18.36 |
| 4th DOWN Forecast | -31.19 |
TransCode Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : RNAZ )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RNAZ Business Profile
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs for the treatment of metastatic diseases. The company's lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. Its products in discovery and preclinical stage include MicroRNA-10b, TTX-siPDL1, TTX-siLIN28b, and TTX-RIGA, which focuses on treating various cancers. The company was incorporated in 2016 and is based in Boston, Massachusetts. Address: 6 Liberty Square, Boston, MA, United States, 02109
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service